Counselors in Cabot, PA Accepting Medicare
2 Counselors found. Showing 1 - 2
 Kristen Mari Haugh, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 430 Bicker Rd, Cabot, PA 16023 Phone: 412-430-1858 |
Sarah Greene Mikoloski, MS Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1266 Cornplanter Rd, Cabot, PA 16023 Phone: 814-558-3958 |
News Archive
Teva Pharmaceutical Industries reaches settlement in principle to resolve claims under federal, state False Claims Acts
Teva Pharmaceutical Industries Ltd. announced today that several of its subsidiaries in the United States reached a settlement in principle to resolve claims brought by Ven-A-Care of the Florida Keys, Inc. on behalf of the United States, Texas, Florida, and California under federal and state False Claims Acts.
Scripps Proton Therapy Center reports exceptional results in treating patients with pencil-beam scanning
The nation's first and only proton therapy center to treat patients exclusively with pencil-beam scanning is reporting exceptional results in delivering cancer treatment since opening for patient care just more than a year ago.
Many rural health care providers do not routinely screen women for IPV, say Penn State researchers
Many primary care physicians in rural communities do not routinely screen women for intimate partner violence (IPV), according to Penn State medical and public health researchers. Rural women who are exposed to such violence have limited resources if they seek help.
New GWA can pose major ethical problems if used incorrectly, say ESHG recommendations
The use of genome-wide analysis, where the entirety of an individual's DNA is examined to look for the genomic mutations or variants which can cause health problems is a massively useful technology for diagnosing disease.
Portola Pharmaceuticals commences Phase 1 trial of PRT062607 for chronic inflammatory diseases
Portola Pharmaceuticals, Inc. today announced that it has initiated its first in human Phase 1 trial in healthy volunteers of PRT062607, a novel, oral Syk-specific kinase inhibitor in development to treat chronic inflammatory diseases, including rheumatoid arthritis (RA), and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. In preclinical in vivo models of RA, PRT062607 was shown to reduce inflammation in a dose-dependent manner.
› Verified 5 days ago